Related Experiment Video
Updated: Jul 25, 2025
Microfluidic Platform with Multiplexed Electronic Detection for Spatial Tracking of Particles
Published on: March 13, 2017
Multiplexed detection of biomarkers using a microfluidic chip integrated with mass-producible micropillar array
Chaozhan Chen1, Bin Ran1, Bo Liu1
1School of Science, Harbin Institute of Technology, Shenzhen, Shenzhen, 518055, PR China; School of Mechanical Engineering and Automation, Harbin Institute of Technology, Shenzhen, Shenzhen, 518055, PR China; Center for Microflows and Nanoflows, Harbin Institute of Technology, Shenzhen, Shenzhen, 518055, PR China.
This study developed a novel microfluidic device with enhanced electrodes for sensitive detection of multiple biomarkers in small samples. The biosensor shows promise for point-of-care diagnostics and personalized health monitoring.
Area of Science:
- Electrochemistry
- Materials Science
- Biomedical Engineering
Background:
- Accurate quantification of multiple biomarkers in small biological samples is crucial for point-of-care testing.
- Existing methods often lack the sensitivity or multiplexing capability required for early disease detection.
Purpose of the Study:
- To develop a novel microfluidic device integrated with mass-producible micropillar array electrodes (μAEs) for sensitive multiplexed biomarker detection.
- To enhance the electroanalytical performance of the electrodes using platinum-palladium (Pt-Pd) bimetallic nanoclusters (BNC).
Main Methods:
- Mass fabrication of micropillar array electrodes (μAEs) using soft lithography and hot embossing.
- Modification of μAEs with Pt-Pd BNC via constant potential (CP)/multi-potential step (MPS) electrodeposition.
- Electrochemical detection of hydrogen peroxide (H2O2), glucose, uric acid, and sarcosine.
Main Results:
- Pt-Pd BNC/μAEs demonstrated significant sensitivity enhancement (56.5x for H2O2 vs. planar electrodes, 9.5x vs. bare μAEs).
- High sensitivity detection of glucose, uric acid, and sarcosine with wide linear ranges and low limits of detection (LOD).
- Achieved LODs: 58.5 μM for glucose, 3.4 μM for uric acid, and 0.4 μM for sarcosine.
Conclusions:
- The developed microfluidic device with Pt-Pd BNC/μAEs offers a highly sensitive platform for multiplexed biomarker detection.
- The device's performance in human serum indicates its potential for clinical diagnostics and self-health management.
- This technology advances the field of point-of-care testing by enabling precise analysis of multiple biomarkers from minimal sample volumes.
